Premacio, Reynaldo .

HRN: 26-76-86  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/04/2025
CEFUROXIME 750MG (VIAL)
03/04/2025
03/11/2025
IV
750
Q8
T/c Nephrolitgiasis
Rejected 
03/04/2025
CEFTRIAXONE 1G (VIAL)
03/04/2025
03/04/2025
IV
2g
Now
Nephrolithiasis
Waiting Final Action 
03/04/2025
CEFTRIAXONE 1G (VIAL)
03/04/2025
03/11/2025
IV
1g
Q12
Nephrolithiasis
Waiting Final Action 
03/14/2025
CEFTRIAXONE 1G (VIAL)
03/14/2025
03/21/2025
IV
1 Gram
Q12H
S/P Bilateral DJ Stenting
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: